A Specifically Designed Stent for XXXX after Bariatric Surgery: Experiences in a Tertiary Referral Hospital.

@entity1 @entity834
BACKGROUND: The management of @entity834 after either laparoscopic Roux-en-Y gastric bypass (LGBP) or laparoscopic sleeve gastrectomy (LSG) remains a burden. Various options are available for the treatment of these leaks. A newer and less invasive option for the treatment of leaks is the use of endoluminal stents. The main drawback for this treatment is stent migration. The current study describes the outcome of a new, specifically designed stent for the treatment of @entity834 after bariatric surgery. METHODS: For this retrospective observational study, the medical charts of @entity1 undergoing bariatric surgery between October 1, 2010 and July 1, 2013 were reviewed. All @entity1 with @entity834 , treated with the bariatric Hanarostent, were included. RESULTS: Twelve @entity1 were included out of a total of 1702 bariatric @entity1 in the described period. Seven had a leakage after LSG, five after LGBP. An average of 2.4 endoscopic procedures and 1.25 stents were used per @entity1 . Successful treatment was seen in nine out of 12 @entity1 (75  %). Most common complication was dislocation or migration of the stent, occurring in eight @entity1 (66.7  %). CONCLUSIONS: The ECBB Hanarostent  , which was specifically designed for post bariatric leakages, shows equal but not favorable success rates in this small series compared to previous reports on other types of stenting techniques. Despite the stent design, the complication rate is not reduced and the main future goal should be to target the high stent migration rate.
